+7 (343) 270-75-00

          info@uphc.ru

News

From April 15 to 18, Ekaterinburg hosted the 6th international specialized exhibition and forum Healthcare of the Urals–2025. This year, 130 companies from 34 cities of Russia and the Republic of Belarus took part in the event, presenting over 1000 units of medical equipment and goods. The residents of the Ural Biomedical Cluster were traditionally among the participants, as well as its collective member – the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.

On April 6, the First Children's Polyclinic in the Akademichesky District celebrated its 10th anniversary. During this time, the institution has become a flagship of high-quality and affordable medical care for children, serving 33,083 young patients. The polyclinic was created by the initiative of the Ural Biomedical Cluster and the Governor of the Sverdlovsk Region and became a successful example of public-private partnership.

A meeting of the Committee on Entrepreneurship in Healthcare and Medical Industry of the Ural Chamber of Commerce and Industry was held in Ekaterinburg on March 18, 2025, chaired by Alexander Petrov. Participants of the event, including representatives of the Association of Medical Specialists for Risk Modification, the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region, the Ural Biomedical Cluster and members of the Committee considered key challenges in maintaining the health of the able-bodied population, fighting against socially significant diseases and regulating prices for vital drugs.

The Russian pharmaceutical industry has gained significant stability in the recent years thanks to manufacturers such as Medsintez Plant. This is a modern full-cycle biotechnological enterprise that develops and manufactures pharmaceutical ingredients and drugs that meet international GMP and ISO standards.

  • Home
  • Cluster members
  • Postovsky Institute of Organic Synthesis Ural Branch of the Russian Academy of Sciences

Postovsky Institute of Organic Synthesis Ural Branch of the Russian Academy of Sciences

Created by the decision of the Presidium of the Russian Academy of Sciences dated 29.06.93, however, it has deep historical roots, being, in fact, one of the first scientific institutions of the Ural Branch of the Russian Academy of Sciences. In 1932, with the direct participation of Academician I.Ya. Postovsky, was established the Institute of Chemistry of the Ural Branch of the USSR Academy of Sciences, which organic chemical laboratories became the basis of the institute.

The institute includes 5 laboratories and 4 groups. On the basis of the Institute of Organic Synthesis, there are branches of the Departments of Organic Chemistry of the Ural Federal University, joint laboratories with the Department of High- Molecular Compositions of the Ural Federal University and the Faculty of Chemistry of the Chelyabinsk State University, Research Equipment Sharing Center of the Ural Branch of the Russian Academy of Sciences “Spectroscopy and Organic Compound Analysis”, laboratory of the Ural Scientific and Educational Center “Advanced Materials”.

Development of the Institute is based on the following guidelines:
1. Combining the best traditions of the Urals scientific school of organic chemists with innovative approaches to development of fundamental research aimed at creating new methodologies for organic synthesis, taking into account the latest achievements of world science in such important areas as C-H functionalization of aromatic and heteroaromatic substances, synthesis of enantiomerically pure biologically active compounds, chemistry of fluorine-containing compounds, chemistry of organo(boron)element compounds, asymmetric catalysis, supramolecular and coordination chemistry, transformations of heterocycles, electro- and photosynthesis, chemistry of monomers and polymers, gas-, oil- and coal chemistry.
2. Reasonable balance of fundamental and applied research. Development of fundamental research in organic synthesis, focused on creation of drugs combating infectious diseases of viral and bacterial etiology, including those active against viruses, bacteria and mycobacteria with multidrug resistance, as well as anticancer, anti-inflammatory and other chemotherapeutic agents. Medical and biological studies of drugs as part of preclinical and clinical studies thereof.
3. Development of fundamental and applied research in the field of organic materials science, as the most important direction of the Strategy for Scientific and Technological Development of the Russian Federation. Strengthening cooperation with universities and enterprises of the real sector of economy. Carrying out a full cycle of research and development applied work to create new organic materials for medicine and technology, including for enterprises of the military- industrial complex, including development of materials, methods and technologies for production thereof.

www.ios.uran.ru